RBC Capital analyst Arun Viswanathan upgraded Chemours Co (NYSE: CC) from Sector Perform to Outperform.
Viswanathan also raised the price target to $40 from $28 — an upside of 40.6%. Increased optimism on TiO2 margin recovery, strong TSS performance, and PFAS liabilities settlement drive the upgrade and price rise.
Viswanathan expects TT volumes to rise in 2024 with favorable comps and potential tariffs on Chinese imports into Europe.
Related: PFAS's Forever Problem - Ohio Lawsuit Against Chemical Companies Fizzles Out
The analyst points out that the TSS segment is thriving, largely thanks to rising OPTEON adoption ahead of the 2024 HFC step-down. CC anticipates that OPTEON and immersion ...